Target Price | CHF4,150.67 |
Price | CHF3,841.00 |
Potential | 8.06% |
Number of Estimates | 21 |
21 Analysts have issued a price target Givaudan 2026 . The average Givaudan target price is CHF4,150.67. This is 8.06% higher than the current stock price. The highest price target is CHF4,900.00 27.57% , the lowest is CHF3,400.00 11.48% . | |
A rating was issued by 23 analysts: 8 Analysts recommend Givaudan to buy, 10 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Givaudan stock has an average upside potential 2026 of 8.06% . Most analysts recommend the Givaudan stock at Hold. |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 7.41 | 7.73 |
7.19% | 4.31% | |
EBITDA Margin | 23.87% | 24.10% |
12.12% | 0.98% | |
Net Margin | 14.72% | 14.79% |
13.88% | 0.51% |
20 Analysts have issued a sales forecast Givaudan 2025 . The average Givaudan sales estimate is CHF7.7b . This is 4.31% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.0b 7.39% , the lowest is CHF7.5b 1.38% .
This results in the following potential growth metrics:
2024 | CHF7.4b | 7.19% |
---|---|---|
2025 | CHF7.7b | 4.31% |
2026 | CHF8.1b | 4.68% |
2027 | CHF8.5b | 5.12% |
2028 | CHF9.1b | 6.78% |
2029 | CHF9.7b | 6.92% |
20 Analysts have issued an Givaudan EBITDA forecast 2025. The average Givaudan EBITDA estimate is CHF1.9b . This is 5.33% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF1.9b 8.99% , the lowest is CHF1.7b 5.91% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF1.8b | 20.18% |
---|---|---|
2025 | CHF1.9b | 5.33% |
2026 | CHF2.0b | 4.96% |
2027 | CHF2.1b | 5.44% |
2028 | CHF2.1b | 4.14% |
2029 | CHF2.2b | 1.44% |
2024 | 23.87% | 12.12% |
---|---|---|
2025 | 24.10% | 0.98% |
2026 | 24.17% | 0.29% |
2027 | 24.24% | 0.29% |
2028 | 23.64% | 2.48% |
2029 | 22.43% | 5.12% |
14 Givaudan Analysts have issued a net profit forecast 2025. The average Givaudan net profit estimate is CHF1.1b . This is 4.83% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.2b 9.40% , the lowest is CHF1.1b 1.82% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.1b | 22.06% |
---|---|---|
2025 | CHF1.1b | 4.83% |
2026 | CHF1.2b | 8.17% |
2027 | CHF1.3b | 7.94% |
2028 | CHF1.4b | 2.92% |
2029 | CHF1.4b | 1.35% |
2024 | 14.72% | 13.88% |
---|---|---|
2025 | 14.79% | 0.51% |
2026 | 15.28% | 3.31% |
2027 | 15.69% | 2.68% |
2028 | 15.13% | 3.57% |
2029 | 14.34% | 5.22% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 118.17 | 123.87 |
22.06% | 4.82% | |
P/E | 31.01 | |
EV/Sales | 5.10 |
14 Analysts have issued a Givaudan forecast for earnings per share. The average Givaudan EPS is CHF123.87 . This is 4.82% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF129.28 9.40% , the lowest is CHF116.02 1.82% .
This results in the following potential growth metrics and future valuations:
2024 | CHF118.17 | 22.06% |
---|---|---|
2025 | CHF123.87 | 4.82% |
2026 | CHF133.99 | 8.17% |
2027 | CHF144.63 | 7.94% |
2028 | CHF148.85 | 2.92% |
2029 | CHF150.87 | 1.36% |
Current | 32.50 | 20.36% |
---|---|---|
2025 | 31.01 | 4.58% |
2026 | 28.67 | 7.55% |
2027 | 26.56 | 7.36% |
2028 | 25.80 | 2.86% |
2029 | 25.46 | 1.32% |
Based on analysts' sales estimates for 2025, the Givaudan stock is valued at an EV/Sales of 5.10 and an P/S ratio of 4.58 .
This results in the following potential growth metrics and future valuations:
Current | 5.32 | 9.68% |
---|---|---|
2025 | 5.10 | 4.14% |
2026 | 4.87 | 4.47% |
2027 | 4.63 | 4.87% |
2028 | 4.34 | 6.35% |
2029 | 4.06 | 6.48% |
Current | 4.78 | 9.31% |
---|---|---|
2025 | 4.58 | 4.13% |
2026 | 4.38 | 4.47% |
2027 | 4.17 | 4.87% |
2028 | 3.90 | 6.35% |
2029 | 3.65 | 6.47% |
Analyst | Rating | Action | Date |
---|---|---|---|
RESEARCH PARTNERS AG |
Buy
➜
Buy
|
Unchanged | Apr 02 2025 |
BERENBERG |
Hold
➜
Buy
|
Upgrade | Mar 31 2025 |
ESN/CIC MARKET SOLUTIONS |
Neutral
➜
Neutral
|
Unchanged | Mar 30 2025 |
BAADER HELVEA EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Mar 25 2025 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Mar 20 2025 |
JEFFERIES |
Underperform
➜
Underperform
|
Unchanged | Mar 12 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RESEARCH PARTNERS AG:
Buy
➜
Buy
|
Apr 02 2025 |
Upgrade
BERENBERG:
Hold
➜
Buy
|
Mar 31 2025 |
Unchanged
ESN/CIC MARKET SOLUTIONS:
Neutral
➜
Neutral
|
Mar 30 2025 |
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
➜
Buy
|
Mar 25 2025 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Mar 21 2025 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Mar 20 2025 |
Unchanged
JEFFERIES:
Underperform
➜
Underperform
|
Mar 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.